Gennova Biopharmaceuticals gets DCGI nod for mRNA-based Covid booster vaccine
GEMCOVAC-OM is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant.
gennova biopharmaceuticals
June 2023
June 2022
India’s first mRNA vaccine against Covid-19 from Gennova gets DCGI approval
Gennova's vaccine will be available for adults above 18 years of age. It will be a two-dose vaccine that will be administered intramuscularly at 28 days apart
